Introduction
Podocytes, as well as their associated highly complex three-dimensional framework, are main components of the kidney filtration barrier. Although this podocyte-based kidney filtration barrier is a highly efficient filtration device that produces a large volume of protein-free ultra-filtrate per day, it is the most vulnerable component of the kidney and is responsible for the majority of progressive kidney diseases leading to end-stage renal disease (ESRD). Podocyte injury is a key determinant of urinary protein loss and can serve as a marker to predict proteinuric glomerular disease progression (1, 2) . Unlike all other cell types forming the kidney filtration complex, podocytes are terminally differentiated cells and have an extremely limited capacity for replacement (3) . On the other hand, podocytes face various challenges including environmental factors such as infection, hyperglycemia and intracellular stress, resulting in the accumulation of damaged proteins, lipids, and organelles (4) . For podocytes to survive and perform filtration barrier function, they must develop the ability to cope with these stresses. Recent studies suggest that glomerular autophagy might be a major mechanism preventing podocyte degeneration (5) . Podocytes maintain a high basal level of autophagic activity and autophagy plays a critical role in the homeostasis of podocytes during glomerular disease and aging (6, 7) . However, the regulatory mechanism underlying the capacity for podocytes to maintain high autophagic activity is poorly understood.
SIRPα, an IgSF family member with two immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in the cytoplasmic tail, plays an important role in modulating almost all aspects of leukocyte immune responses, such as adhesion, migration and phagocytosis (8) . It has been well-documented that SIRPα's function is mainly dependent on its ITIMs (9) (10) (11) . Phosphorylation of SIRPα ITIMs will recruit and activate SHP-1/2, which in turn, dephosphorylate a panel of substrates to initiate various signaling downstream (9) . One such substrate is Akt (12) , which is involved in modulating cell survival and autophagy. It may be SIRPα is also involved in regulating cellular autophagy through its regulation of Akt. The possibility that SIRPα plays a role in autophagy is consistent with the findings that SIRPα level (13) and autophagic activity (14) in leukocytes increase at the same time during cellular maturation. A recent study by Kurihara et al. showed that SIRPα is expressed in podocytes but not other glomerular cells (15) . Interestingly, their study suggests that SIRPα may play a role in 4 glomerular cell-cell communication through interacting with its ligand CD47. The role of podocyte SIRPα in nephropathy development, however, remains unclear.
In the present study, we observe that Sirpa-deficient (Sirpa -/-) mice display significant age-related proteinuria and podocyte injury, and also develop more rapid and severe nephropathy in various mouse models of nephropathy. In line with this, podocyte SIRPα level is reduced in (focal glomerular sclerosis (FSGS) patients and mice treated with puromycin (PAN), adriamycin (ADR) and streptozotocin (STZ). The results show that podocyte SIRPα expression is correlated positively with autophagy activity but negatively with glomerular pathology. Our mechanistic studies suggest that SIRPα modulates the phosphorylation of Akt and subsequent Akt/GSK-3β/β-catenin signaling pathway to control podocyte autophagy. Finally, maintaining podocyte SIRPα levels during glomerular disease progression via delivery of SIRPα-expressing plasmid can reverse PANinduced proteinuria and glomerular damage. Our results demonstrate that podocyte SIRPα serves as a safeguard against podocyte injury through promoting autophagic activity.
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RESULTS
SIRPα deficiency results in murine proteinuria and podocyte injuries from aging
Although Sirpa -/-mice appeared healthy under the standard specific pathogen-free housing conditions, we found that, compared to their wild-type (WT) littermates, Sirpa -/-mice displayed an age-dependent onset of proteinuria (Supplementary Figure 1) , podocyte injury and glomerulosclerosis. As shown in Figure 1A , the albumin-tocreatinine ratio (ACR) in Sirpa -/-mice increased as the mice aged. At 6 months (6M), ACR in Sirpα -/-mice was significantly higher than that in WT mice. At 20 months (20M), more than 60% of Sirpa -/-mice developed albuminuria >300 mg/l compared to only ~15% of WT mice ( Figure 1B ). Histological analysis of WT and Sirpa The ultrastructure of murine glomeruli was further analyzed using transmission electron microscopy (TEM). As shown in Figure 2A , more severe foot process fusion (black solid arrowheads), foot process effacement (black hollow arrowheads) and glomerular basement membranes (GBM) thickness was observed in glomeruli of 6, 12
and 20 months Sirpa -/-mice than WT mice at the same age. A larger number of vacuoles (black arrows) were also found in podocytes from 20 months Sirpa -/-mice than WT mice ( Figure 2B ). Given that podocytes can synthesize the matrix components of GBM (16) , the irregular thickening of the GBM that we observed in SIRPα knockout mice by 6 months of age may be caused by the impaired podocytes. We thus analyzed the detailed ultrastructure of podocytes, including microvillus formation, ER and mitochondria. As shown in Figure 2B , aging Sirpa -/-mice displayed obvious abnormalities such as microvillus formation (black hollow arrowheads), distension of rough ER (red solid arrowheads) and damaged mitochondria (red solid stars) in podocytes compared to WT mice (red hollow arrowheads and stars) which showed no such structural disruption in their podocytes. Lipofuscin is one of the best markers of aging and the accumulation of lipofuscin has been related to mitochondrial damage and oxidative stress (17) . As lipofuscin cannot be completely hydrolyzed due to its dense structure or released from cells, it will affect the cellular metabolism and promote cell senescence when 6 it accumulates in the cell. Therefore, we measured the degree of lipofuscin accumulation in podocytes of Sirpa -/-mice. As shown in Figure 2C , the prominent accumulation of lipofusin (red arrows) in podocytes of Sirpa -/-mice by 6 months of age indicated that SIRPα deficiency accelerated the degeneration and aging of podocytes.
Podocyte SIRPα is significantly downregulated in nephropathy
To explore how SIRPα deficiency leads to aged-associated murine proteinuria and podocyte injuries, we first examined the distribution of SIRPα in murine kidneys. As shown in Figure 3A , double staining of murine kidney tissue sections with antibodies against SIRPα (green) or nephrin (red), a podocyte marker, showed perfect colocalization of SIRPα and nephrin in murine glomeruli, suggesting that SIRPα is expressed in podocytes but not other glomerular cells. Co-localization of SIRPα with podocin, another podocyte marker protein, was also ( Figure 3D , right) were differentiated to functional podocytes, SIRPα expression in differentiated podocytes was strongly increased compared to that in undifferentiated cells.
Given that podocytes specifically express SIRPα, we examined the level of podocyte SIRPα when podocytes were injured. In this experiment, WT mice were treated with PAN (18), ADR (19) or STZ (20) as previously A decrease in podocyte SIRPα was also detected in patients with ongoing focal segmental glomerulosclerosis (FSGS). In this experiment, frozen sections of biopsy samples were obtained from healthy subjects (n=2) and 17 FSGS patients (Table 1 and 2). As shown in Figure 4C , glomerular immunostaining of SIRPα (green) and nephrin (red) revealed that SIRPα was co-localized with nephrin and heavily expressed in human podocytes, and that the level of podocyte SIRPα was significantly reduced in FSGS patients compared to healthy controls.
We further analyzed the correlation between podocyte SIRPα level and severity of proteinuria. 17 FSGS patients were further separated into two groups according to their proteinuria content within 24 h: Low group, proteinuria Figure 5B), foot process fusion and GBM thickness ( Figure 5C , arrowheads) and loss of podocytes ( Figure   5D ), indicating that SIRPα deficiency promotes the development of murine glomerular diseases. As actin cytoskeletal complex rearrangement plays a critical role in foot process fusion (21), we also stained cultured human podocytes from human podocyte cells (HPC) transfected with overexpressing-plasmid of SIRPα with phalloidin after treatment with or without HG and PAN. As shown in Figure 5E , even after treated with HG or PAN, the SIRPα-overexpressing podocytes largely maintained their central stress fiber formation. These results collectively suggest that SIRPα plays an important role in protecting the integrity of podocytes against glomerular disease progression.
SIRPα protects podocytes under stress through promoting autophagic activity in vitro
Recent studies have shown that podocytes have a high basal level of autophagic activity and autophagy plays a crucial protective role for podocytes during the progression of glomerular aging and diseases (6, 22, 23 Figure 5A and B) in WT podocytes increased after PAN or HG treatment. Autophagic flux is also induced by PAN or HG treatment (Supplementary Figure 5C ). We also examined the effect of SIRPα on the expression of podocyte-specific protein podocin. As shown in Supplementary Figure 6 , the level of podocin was decreased after SIRPα knockdown but increased after SIRPα As p62/SQSTM1, a scaffold protein that is marked for destruction following ubiquitinylation (27) , plays a critical role in regulating autophagy (28), we assessed the level of p62 and found that transfection with SIRPα siRNA lentivirus increased, while transfection with SIRPα-expressing lentivirus decreased the accumulation of p62 ( Figure 6D ). This result suggests that SIRPα may modulate p62 degradation under stressed conditions. Furthermore, the lysosomal activity in HPCs treated with PAN was also measured. As shown by Lyso-Tracker
Green staining in Figure To identify the downstream pathway of the functional effect of SIRPα in podocyte, we overexpressed SIRPα in
HPCs and analyzed phospho-kinase activation. Whole-cell extracts from HPCs transfected with control lentivirus or SIRPα-overexpressing lentivirus were incubated with a human phospho-kinase array to compare kinase's phosphorylation affected by SIRPα ( Figure 6G ). Several kinases, including p-GSK-3α/β (S21/S9), pAkt1/2/3 (S473) and β-catenin were downregulated by SIRPα. Furthermore, the control lentivirus or SIRPα-overexpressing lentivirus-transfected HPCs treated with PAN and the expression of p-GSK-3α/β, GSK-3α/β, pAkt, Akt, p-β-catenin and β-catenin were analyzed by western blotting. As shown in Figure 6H , SIRPα significantly downregulated the phosphorylation of GSK-3α/β, Akt and β-catenin.
SIRPα facilitates podocytes to adapt to stress condition through promoting autophagy in vivo
To analyze protective role of SIRPα as mediated through autophagy in vivo, we crossed transgenic mice expressing GFP-LC3 with Sirpa -/-mice (Sirpa To definitely demonstrate that autophagy is involved in the protection of podocytes under stress in vivo, we also treated 8-week-old SIRPα deficient mice with PAN and rapamycin. As shown in Figure 8 , rapamycin treatment significantly ameliorated PAN-induced proteinuria ( Figure 8A ), pathological damage of glomerulus ( Figure 8B) and foot process fusion of podocytes and GBM thickness ( Figure 8C ) in Sirpa -/-mice. Furthermore, rapamycin induced GFP-LC3-positive autophagosomes ( Figure 8D ) and decreased accumulation of p62 ( Figure 8E and F) in Sirpa -/-mice. These results further suggest that autophagy is involved in the protection of podocytes under stress condition, and mTOR signaling pathways play an important role in SIRPα-regulated autophagy in vivo.
Overexpression of SIRPα reverses murine PAN-induced proteinuria and renal damage through activating autophagy
We studied the effect of SIRPα on the progression of renal abnormalities and glomerular pathology in PANtreated mice by injection of SIRPα-expressing plasmids into the tail vein of mice every 3 days after the onset of glomerular diseases. By employing the hydrodynamic delivery strategy previously used to deliver plasmid into podocytes (29), we successfully delivered SIRPα-expressing plasmids into glomeruli. As shown by western blotting ( Figure 9A ) and immunofluorescent labeling ( Figure 9B ), SIRPα-expressing plasmids significantly increased the protein level of SIRPα in glomeruli. Following PAN treatment, PAN-induced murine proteinuria ( Figure 9C ), pathological damage of glomerulus ( Figure 9D ), foot process fusion and GBMs thickness ( Figure   9E ) were significantly improved in mice given SIRPα-expressing plasmids compared to that of control mice.
Consistent with this, murine podocyte autophagic activity was remarkably enhanced by SIRPα overexpression ( Figure 9F ), while p62 accumulation was significantly reduced by SIRPα overexpression ( Figure 9G and H).
These data confirm that increased SIRPα in podocytes can reverse renal abnormalities and glomerular pathology induced by PAN.
Discussion
Autophagy plays a critical role in podocyte survival. It has been well-documented that healthy podocytes maintain a high autophagic activity, and that high autophagic activity leads to enhanced survival (30) (31) (32) .
However, the molecular mechanism that governs podocyte autophagy had been incompletely understood. In the present study, we demonstrate that podocyte autophagy is controlled by SIRPα, while SIRPα deletion leads to the impairment of podocyte autophagy and development of podocyte dysfunction. The mTOR pathway is a key regulatory cascade that controls cell proliferation and survival through increasing autophagy (31, 33, 34) . It has been shown that mTOR is activated by multiple kinases such as Akt (35) (36) (37) and MAPK (38) , but how the dynamic process of Akt phosphorylation is regulated remains elusive. Our mechanistic study shows that SIRPα controls the phosphorylation of Akt as well as the GSK-3β/β-catenin signal pathway.
In agreement with this, a previous study reported that knockdown of SIRPα prolongs activation of PI3K-Akt pathways in macrophages, leading to an increased capacity for macrophages to promote inflammation (39) . In addition, Petherick et al. revealed that β-catenin signaling could suppress cellular autophagic activity (40) .
Given that β-catenin signaling is inhibited by the overexpression of SIRPα ( Figure 6G and H), SIRPα may promote podocyte autophagy through suppressing β-catenin signaling. The negative correlation between SIRPα level and β-catenin signaling has been previously reported by Maekawa et al. who showed that SIRPα knockdown by stable transfection of SIRPα siRNAs can induce β-catenin in leukemia cells (41) . Taken together, 13 our results suggest that SIRPα may promote podocyte autophagic activity through controlling Akt/mTOR and Wnt/β-catenin signals.
It is widely accepted that rearrangement of podocyte cytoskeletal complex plays a critical role in foot process effacement (21, 42, 43) . As more severe proteinuria developed in Sirpa -/-mice during aging or following various nephropathy challenges is tightly correlated with massive foot process effacement of podocytes, it may suggest a functional link between podocyte cytoskeleton alterations and SIRPα-modulated autophagy. Through gain-offunction and loss-of-function assays in differentiated podocyte cells, we validated the critical role of SIRPα in maintaining the cytoskeleton structure of podocytes, suggesting that SIRPα may be essential for preserving the integrity of podocytes. Supporting this notion is the recent finding that SIRPα interacts with nephrin, an important component of architecture (44, 45) , at the podocyte slit diaphragm (46) .
Given that SIRPα reduction in podocytes was observed in FSGS patients and mice treated with various nephropathy inducing challenges, a rapid decrease of podocyte SIRPα level may be a common phenomenon in glomerular diseases. However, the mechanism by which podocyte SIRPα is downregulated remains unknown.
Since SIRPα mRNA is detected in various cells and tissues but SIRPα protein expression is highly restricted in certain cell types, mainly myeloid derived leukocytes, neural cells and podocytes, it is likely that SIRPα expression is modulated at the post-transcriptional level. Our previous study showed that SIRPα is a common target of miR-17, miR-20a and miR-106a in macrophages, and the levels of these three miRNAs are strongly increased under inflammatory conditions (47) . A hypothesis for future testing is that SIRPα reduction in podocytes is achieved via enhanced expression of miR-17, miR-20a and miR-106a during the development of glomerular diseases. In addition to directly affect podocytes, SIRPα may have different functional effects in various organs since our experiments in the present study are performed not in podocyte-specific SIRPα-knockout mice. It will be necessary to generate podocyte-specific SIRPα-deficient mice to define the protective effect of SIRPα on podocytes. In conclusion, the present study demonstrates a critical role of SIRPα in facilitating podocyte survival via promoting autophagic activity and provides insight that SIRPα may serve as a novel therapeutic target for glomerular disease treatment.
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Materials and Methods
Patients. The patients with FSGS (n=17) were enrolled in this study. All protocols concerning the use of patient samples in this study were approved by the Human Subjects Committee of Jinling Hospital, Nanjing University School of Medicine (Nanjing, China). A signed consent form was obtained from each donor. All FSGS patients were diagnosed based on renal biopsies at the National Clinical Research Center of Kidney Diseases, Jinling
Hospital, Nanjing University School of Medicine. Patient exclusion criteria included obesity, diabetes mellitus, HBV infection, hepatitis or malignant tumors and participation in continuous renal replacement therapy. They were further grouped according to the proteinuria content within 24 h (Low group, the occurrence of proteinuria <3g/d; High group, the occurrence of proteinuria >3g/d). Table 1 listed the demographics/clinical characteristics of FSGS patients. Table 2 provides other relevant details of individual patient.
Study approval. Studies using human samples were carried out in accordance with approved guidelines from the local committee on human subjects at Jinling Hospital, Nanjing University School of Medicine, China (2017NZKY-013-01). All participants provided written informed consent for participation. All animal protocols and procedures were approved by the Institutional Animal Care and Use Committee at Nanjing University,
China.
Mice. We performed all animal care and experiments according to the guidelines of the Institutional Animal Care and Use Committee at Nanjing University. The male C57BL/6J (8 weeks, 22-25 g) and GFP-LC3 transgenic mice were obtained from the Model Animal Research Center of Nanjing University (Nanjing, China).
The Sirpa -/-mice were described previously (48) . All mice were backcrossed to a C57BL/6 background. To monitor the autophagy of Sirpa -/-mice, Sirpa -/-mice were crossed with GFP-LC3 transgenic mice.
Cell culture and treatment. Human and mouse podocyte cell lines were kind gifts from Professor M. Saleem (Children's Renal Unit, Bristol Royal Hospital for Children, University of Bristol, UK) and Professor Stuart J.
Shankland (University of Washington, Seattle, WA, USA) and were cultured as previously described (49, 50) .
Cells were seeded onto type I collagen-coated culture plates and cultured in RPMI 1640 medium enriched with 15 10% FBS, 100U/ml penicillin and 100μg/ml streptomycin (Gibco, Gaithersburg, MD, USA). The cells were cultured at 33℃ and 5% CO2 for proliferation, and were then shifted to 37℃ and 5% CO2 for differentiation 
Proteinuria induced by PAN, ADR or STZ. For PAN-induced proteinuria, mice received two intravenous
injections of PAN (180 mg/kg bodyweight, Sigma-Aldrich) on day 0 and day 2. Urinary albumin-creatinine ratios were analyzed before and 7, 14 and 21 days after the injection. Kidneys were harvested and processed for autophagy analysis, WT1 detection, PAS staining and electron microscopy after the 14-day follow-up. For ADR-induced proteinuria, mice received one intravenous injection of ADR (Sigma-Aldrich) in saline (15mg/kg bodyweight). Urinary albumin-creatinine ratios were analyzed before injection and 2, 4, 8 weeks after injection.
Kidneys were harvested and processed for autophagy analysis, WT1 detection, PAS staining and electron microscopy after the 4-week follow-up. For STZ-induced proteinuria, mice received one intraperitoneal injection of STZ (50mg/kg bodyweight, Sigma-Aldrich) in 100mM citrate/sodium citrate each day for 5 days.
Urinary albumin-creatinine ratios were analyzed before and 3, 6, 9 weeks after injection. In addition, blood glucose levels were measured at every point in time. Kidneys were harvested and processed for autophagy analysis, WT1 detection, PAS staining and electron microscopy after the 6-week follow-up. quantified using Image J software. Kidney tissues from patients were embedded in paraffin and sectioned at 3.5μm thickness (Leica CM1950). Paraffin sections were dewaxed, rehydrated and blocked in 3% H2O2 in 70% methanol followed by incubation for 20 min at 65°C in AP assay buffer (100 mM Tris, pH 9.5 containing 100 mM NaCl and 5 mM MgCl2). Sections were washed with phosphate buffered saline (PBS) for three times.
SIRPα overexpression to rescue PAN-induced proteinuria. For expressing
Rabbit anti-human SIRPα antibody was applied for 1 h at 37°C. Afterwards, secondary antibody added and incubated for 45 minutes at 37°C. Sections were finally stained with 3, 3' diaminobezidin (DAB). The protein expression was quantified using Image J software.
Transmission electron microscopy. Kidney tissues were fixed in 4% paraformaldehyde, dehydrated in graded alcohols, and embedded in paraffin. 2μm sections were cut and stained with periodic acid-Schiff reagent. All slides were evaluated by the same pathologist, who was blinded to the identities of the specimens, using a Nikon E800 microscope (Tokyo, Japan). Transmission electron microscopy was performed as previously described (19) . In brief, renal tissues were collected and dissected into 1 mm 3 pieces and fixed in 3.75%
glutaraldehyde, followed by post-fixation in 2% osmium tetroxide, dehydrated in graded acetones ethanol and embedded in epoxy resin (SPI Inc., Westchester, PA, USA). 80-90 nm ultrathin sections were stained for 15 min in 5% uranyl acetate followed by 0.1% lead citrate for 5 min. Electron micrographs were obtained and analyzed using the Hitachi 7500 transmission electron microscope.
Albumin/creatinine ratio detection. Coomassie gels were used to semi-quantitatively confirm the proteinuria of different ages of Sirpa -/-mice and WT mice. Urinary albumin and creatinine were measured using mouse albumin ELISA (Bethyl Laboratories) and creatinine Assay (Sigma-Aldrich) kits according to the manufacturers' protocols. Urine albumin excretion was expressed as the ratio of albumin to creatinine (mg/mg).
Isolation of mouse glomeruli. Glomeruli were isolated using Dynabead perfusion (54) . Briefly, mice were first perfused with pre-warmed bead solution and followed with enzymatic digestion buffer (300U/ml Collagenase type II, 1 mg/ml Proteinase and 50U/ml Dnase I in bead solution) (Sigma-Aldrich). Kidney tissues were minced into 1 mm 3 pieces, and digested in enzymatic digestion buffer at 37°C for 15 min on a rotator (100 rpm).
Digested tissues then were passed through a 100μm cell strainer and collected by centrifugation. The pellet was re-suspended in Hanks' buffered salt solution and glomeruli were washed and collected using a magnet.
Statistical analysis. All of the data were presented as the mean ± SD. When only two groups were compared, Student's t test was used. Comparisons involving multiple dependent measures were Tukey-Kramer corrected.
The reported P value was 2-sided. The differences at the **P<0.01 level and the *P<0.005 level were considered significantly different. 
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